REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
104,986,330
Total 13F shares
72,958,000
Share change
+941,988
Total reported value
$32,934,634,624
Put/Call ratio
151%
Price per share
$451.48
Number of holders
504
Value change
+$441,453,646
Number of buys
226
Number of sells
237

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2015

As of 31 Mar 2015 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 504 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 72,958,000 shares of stock of the company.
Largest 10 holders included Capital World Investors, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, SANDS CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JPMORGAN CHASE & CO, Artisan Partners Limited Partnership, and BlackRock Fund Advisors.
This table shows 504 institutional shareholders of the security as of 31 Mar 2015.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.